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Chikungunya-
related Fatality 
Rates, Mauritius, 
India, and 
Reunion Island 
To the Editor: During the epi-
demic of chikungunya virus infection 
that occurred on Reunion Island in 
2005–06, we reported an overmor-
tality corresponding to the epidemic 
peak, which was estimated by compar-
ing observed and expected deaths (1). 
The excess was similar to the number 
of deaths related to chikungunya in-
fection reported by death certiﬁ  cates 
(2). The case-fatality rate (CFR) on 
Reunion Island was estimated to be 
1/1,000 population.
According to Beesoon et al. (3), 
the fatality rate attributable to chikun-
gunya infection was much higher on 
Mauritius: 743 deaths in excess of ex-
pected deaths led to a CFR of ≈4.5%, 
with 15,760 conﬁ   rmed or suspected 
cases for 2005 and 2006 as reported in 
this letter. A similar CFR of 4.9% can 
be calculated for the city of Ahmeda-
bad, India, during the 2006 chikungu-
nya epidemic (4).
This 45- to 49-fold difference 
could be explained by a greater sever-
ity of chikungunya infection in Mau-
ritius or Ahmedabad that could be due 
to a mutating strain, differences in 
the preexisting conditions of patients, 
differences in the management of pa-
tients, or by coincident deaths in ex-
cess from other causes.
However, the most probable ex-
planation can be attributed to the sur-
veillance systems of chikungunya cas-
es. On Reunion Island, surveillance 
was highly sensitive and relied either 
on active case ﬁ  nding or on estimates 
of suspected cases. Results have been 
assessed by iterative external stud-
ies and serosurveys, and the CFR we 
found is likely consistent.
If we apply this rate to Mauritius, 
≈60% of the population would have 
contracted chikungunya infection dur-
ing this epidemic. If so, the risk of 
epidemic resurgence could be much 
lower than previously expected. This 
point raises the need to conduct sero-
prevalence studies in those territories, 
the only way to evaluate the herd im-
munity level of the population.
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Aquaculture and 
Florfenicol 
Resistance in 
Salmonella enterica 
Typhimurium DT104
To the Editor: In June 2006, the 
World Health Organization (WHO), 
the Food and Agriculture Organiza-
tion of the United Nations (FAO), 
and the World Organisation for Ani-
mal Health (OIE) convened an Expert 
Consultation to consider the risks to 
human health represented by the use 
of antimicrobial drugs in aquaculture. 
This would, therefore, appear to be 
an opportune time to reexamine some 
of the arguments that have been pre-
sented with respect to the assessment 
of these risks.
In their contributions to the de-
bate regarding the risks associated 
with the use of antimicrobial agents in 
aquaculture, Angulo (1), Angulo and 
Grifﬁ  n (2), Ribot et al. (3), and, more 
recently, Cabello (4) have argued that 
the available molecular evidence sug-
gests that the ﬂ  o gene that encodes 
chloramphenicol and ﬂ  orfenicol resis-
tance in Salmonella enterica serovar 
Typhimurium DT104 (DT104) origi-
nally emerged in Japanese aquaculture 
and may have transferred horizontally 
from this host to DT104. This argu-
ment also appears in the report of the 
WHO/FAO/OIE consultation (ftp://
ftp.fao.org/ag/agn/food/aquaculture_
rep_13_16june2006.pdf). These au-
thors (1–4) have based their argument 
on the assertions that ﬂ  orfenicol was 
ﬁ  rst used in Japan and that ﬂ  o gene–
mediated resistance to this agent was 
ﬁ  rst identiﬁ  ed in bacteria isolated from 
Japanese ﬁ  sh farms.
In attempting to identify the date 
of the emergence of ﬂ  orfenicol resis-
tance in Japanese aquaculture, Angu-
lo and Grifﬁ  n (2) state that ﬂ  orfenicol 
had been used in this country since 
the early 1980s. However, Scher-
ing Plough, the manufacturer of ﬂ  o-
rfenicol, reports ﬁ  rst marketing this 
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